Camp4 Therapeutics Balance Sheet Health
Financial Health criteria checks 1/6
Camp4 Therapeutics has a total shareholder equity of $3.2M and total debt of $190.0K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $21.4M and $18.2M respectively.
Key information
6.0%
Debt to equity ratio
US$190.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.53m |
| Equity | US$3.17m |
| Total liabilities | US$18.19m |
| Total assets | US$21.36m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: CAMP's short term assets ($5.5M) do not cover its short term liabilities ($11.8M).
Long Term Liabilities: CAMP's short term assets ($5.5M) do not cover its long term liabilities ($6.4M).
Debt to Equity History and Analysis
Debt Level: CAMP has more cash than its total debt.
Reducing Debt: Insufficient data to determine if CAMP's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CAMP has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CAMP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 3.7% each year